Literature DB >> 34043341

New Interface for Faster Proteoform Analysis: Immunoprecipitation Coupled with SampleStream-Mass Spectrometry.

Henrique Dos Santos Seckler1, Hae-Min Park2, Cameron M Lloyd-Jones1, Rafael D Melani1, Jeannie M Camarillo1, John T Wilkins3, Philip D Compton1,4, Neil L Kelleher1.   

Abstract

Different proteoform products of the same gene can exhibit differing associations with health and disease, and their patterns of modifications may offer more precise markers of phenotypic differences between individuals. However, currently employed protein-biomarker discovery and quantification tools, such as bottom-up proteomics and ELISAs, are mostly proteoform-unaware. Moreover, the current throughput for proteoform-level analyses by liquid chromatography mass spectrometry (LCMS) for quantitative top-down proteomics is incompatible with population-level biomarker surveys requiring robust, faster proteoform analysis. To this end, we developed immunoprecipitation coupled to SampleStream mass spectrometry (IP-SampleStream-MS) as a high-throughput, automated technique for the targeted quantification of proteoforms. We applied IP-SampleStream-MS to serum samples of 25 individuals to assess the proteoform abundances of apolipoproteins A-I (ApoA-I) and C-III (ApoC-III). The results for ApoA-I were compared to those of LCMS for these individuals, with IP-SampleStream-MS showing a >7-fold higher throughput with >50% better analytical variation. Proteoform abundances measured by IP-SampleStream-MS correlated strongly to LCMS-based values (R2 = 0.6-0.9) and produced convergent proteoform-to-phenotype associations, namely, the abundance of canonical ApoA-I was associated with lower HDL-C (R = 0.5) and glycated ApoA-I with higher fasting glucose (R = 0.6). We also observed proteoform-to-phenotype associations for ApoC-III, 22 glycoproteoforms of which were characterized in this study. The abundance of ApoC-III modified by a single N-acetyl hexosamine (HexNAc) was associated with indices of obesity, such as BMI, weight, and waist circumference (R ∼ 0.7). These data show IP-SampleStream-MS to be a robust, scalable workflow for high-throughput associations of proteoforms to phenotypes.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34043341      PMCID: PMC8530194          DOI: 10.1021/jasms.1c00026

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.262


  27 in total

1.  Associations of anthropometry and lifestyle factors with HDL subspecies according to apolipoprotein C-III.

Authors:  Manja Koch; Jeremy D Furtado; Gordon Z Jiang; Brianna E Gray; Tianxi Cai; Frank Sacks; Anne Tjønneland; Kim Overvad; Majken K Jensen
Journal:  J Lipid Res       Date:  2017-04-01       Impact factor: 5.922

2.  A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids.

Authors:  D Wessel; U I Flügge
Journal:  Anal Biochem       Date:  1984-04       Impact factor: 3.365

3.  The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.

Authors:  Margarita de la Llera-Moya; Denise Drazul-Schrader; Bela F Asztalos; Marina Cuchel; Daniel J Rader; George H Rothblat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01-14       Impact factor: 8.311

4.  Apolipoprotein C-III isoforms: kinetics and relative implication in lipid metabolism.

Authors:  Jean-François Mauger; Patrick Couture; Nathalie Bergeron; Benoît Lamarche
Journal:  J Lipid Res       Date:  2006-02-22       Impact factor: 5.922

5.  Relative quantitation of glycoisoforms of intact apolipoprotein C3 in human plasma by liquid chromatography-high-resolution mass spectrometry.

Authors:  Wenying Jian; Richard W Edom; Dai Wang; Naidong Weng; Stanley Weihua Zhang
Journal:  Anal Chem       Date:  2013-02-19       Impact factor: 6.986

6.  HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes.

Authors:  Sridevi Krishnan; Michiko Shimoda; Romina Sacchi; Muchena J Kailemia; Guillaume Luxardi; George A Kaysen; Atul N Parikh; Viviane N Ngassam; Kirsten Johansen; Glenn M Chertow; Barbara Grimes; Jennifer T Smilowitz; Emanual Maverakis; Carlito B Lebrilla; Angela M Zivkovic
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

7.  Novel Interface for High-Throughput Analysis of Biotherapeutics by Electrospray Mass Spectrometry.

Authors:  Hae-Min Park; Valerie J Winton; Jared J Drader; Sheri Manalili Wheeler; Greg A Lazar; Neil L Kelleher; Yichin Liu; John C Tran; Philip D Compton
Journal:  Anal Chem       Date:  2020-01-10       Impact factor: 6.986

8.  Integrated Bottom-Up and Top-Down Proteomics of Patient-Derived Breast Tumor Xenografts.

Authors:  Ioanna Ntai; Richard D LeDuc; Ryan T Fellers; Petra Erdmann-Gilmore; Sherri R Davies; Jeanne Rumsey; Bryan P Early; Paul M Thomas; Shunqiang Li; Philip D Compton; Matthew J C Ellis; Kelly V Ruggles; David Fenyö; Emily S Boja; Henry Rodriguez; R Reid Townsend; Neil L Kelleher
Journal:  Mol Cell Proteomics       Date:  2015-10-26       Impact factor: 5.911

Review 9.  Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer.

Authors:  Kazufumi Honda; Sudhir Srivastava
Journal:  Biomark Med       Date:  2016-09-27       Impact factor: 2.851

10.  Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics.

Authors:  Trisha Tucholski; Wenxuan Cai; Zachery R Gregorich; Elizabeth F Bayne; Stanford D Mitchell; Sean J McIlwain; Willem J de Lange; Max Wrobbel; Hannah Karp; Zachary Hite; Petr G Vikhorev; Steven B Marston; Sean Lal; Amy Li; Cristobal Dos Remedios; Takushi Kohmoto; Joshua Hermsen; J Carter Ralphe; Timothy J Kamp; Richard L Moss; Ying Ge
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-23       Impact factor: 11.205

View more
  2 in total

Review 1.  Is liquid biopsy mature enough for the diagnosis of Alzheimer's disease?

Authors:  Xun Gong; Hantao Zhang; Xiaoyan Liu; Yi Liu; Junlin Liu; Funmilayo O Fapohunda; Peng Lü; Kun Wang; Min Tang
Journal:  Front Aging Neurosci       Date:  2022-08-05       Impact factor: 5.702

Review 2.  The known unknowns of apolipoprotein glycosylation in health and disease.

Authors:  Sabarinath Peruvemba Subramanian; Rebekah L Gundry
Journal:  iScience       Date:  2022-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.